A modified version of vancomycin may offer clues to overcoming antibiotic resistance because of its ability to force its way into bacteria, British researchers have reported.
Scientists found that oritavancin presses into resistant bacteria with a force 11,000 times stronger than vancomycin.
The drug is known as a fast-acting antibiotic and is used to treat complex skin infections.
It gained approval in the USA in 2014, six years after its developers first applied for approval.
The researchers, at University College, London, UK, say it "tears holes" in bacteria, breaking open the drug-resistant locks that evolve in some microbes.
They have reported their findings in Scientific Reports.
Researcher Dr Joseph Ndieyira said the findings would help in the design of new antibiotics.
He said: "Even though it has the same ‘key’ as vancomycin, oritavancin was still highly effective at killing resistant bacteria.
"Until now it wasn’t clear how oritavancin killed bacteria, but our study suggests that the forces it generates can actually tear holes in the bacteria and rip them apart."
He added: "Oritavancin molecules are good at sticking together to form clusters, which fundamentally changes how they kill bacteria.
"When two clusters dig into a bacterial surface they push apart from each other, tearing the surface and killing the bacteria. Remarkably, we found that conditions at the bacterial surface actually encourage clustering which makes antibiotics even more effective."
Scientific Reports 3 February 2017 [abstract]

Leave a Reply